tiprankstipranks
EssilorLuxottica SA (ESLOY)
OTHER OTC:ESLOY
US Market

EssilorLuxottica SA (ESLOY) Earnings Dates, Call Summary & Reports

Compare
129 Followers

Earnings Data

Report Date
Jul 28, 2025
TBA Not Confirmed
Period Ending
2025 (Q2)
Consensus EPS Forecast
1.45
Last Year’s EPS
1.62
Same Quarter Last Year
Based on 0 Analysts Ratings
---

Earnings Call Summary

Earnings Call Date:Feb 12, 2025
|
% Change Since: 7.65%
|
Next Earnings Date:Jul 28, 2025
Earnings Call Sentiment|Positive
The earnings call reflects a strong performance for EssilorLuxottica in 2024, with significant growth in revenue, innovations in smart glasses and hearing aids, and successful expansion in medtech and eye care. However, there were challenges in specific markets like China, India, and Brazil, and the Ray-Ban Meta product had a dilutive impact on profitability. Overall, the positive achievements and innovations outweigh the challenges.
Company Guidance
During the EssilorLuxottica Full Year 2024 Results Management Call, the company reported a revenue growth of 9% in the fourth quarter and 6% for the entire year, driven by strong organic growth and contributions from M&A activities. Key highlights included the successful integration of Supreme and Heidelberg, with Supreme achieving sales growth in line with the group's base. The Stellest line showed a remarkable 60% growth in China and increasing traction in Europe, emphasizing the urgency of addressing myopia globally. The company expanded its adjusted operating margin by 50 basis points in 2024, overcoming inflationary pressures. The Ray-Ban Meta glasses, a collaboration with Meta, sold over 2 million units since its September 2023 launch, with plans to expand production capacity to 10 million units annually by the end of 2025. Additionally, the Nuance audio glasses received FDA clearance for the U.S. market, with plans to launch in Europe, targeting the unmet need for hearing aid solutions. EssilorLuxottica also highlighted its strategic focus on eye care, including diagnostic and surgical guidance capabilities, supported by recent acquisitions and technological advancements.
Strong Revenue Growth
EssilorLuxottica maintained strong revenue growth with a 9% increase in Q4 and a 6% increase for the full year of 2024.
Stellest Performance
Stellest showed significant growth with a 60% increase in revenue in China and gaining traction in Europe.
Operating Margin Expansion
Adjusted operating margin expanded by 50 basis points, despite labor-driven inflationary pressure.
Innovations in Smart Glasses and Hearing Aids
EssilorLuxottica sold over 2 million units of Ray-Ban Meta glasses and launched Nuance Audio hearing aid glasses in the U.S. and Europe.
Strong Performance Across Regions
All regions reported positive growth at constant exchange rates, with Latin America and Asia Pacific just below 10%, EMEA at 8%, and North America at 3% for the full year.
Significant Free Cash Flow Generation
EssilorLuxottica generated EUR 2.4 billion in free cash flow for the full year 2024.
Expansion in Medtech and Eye Care
Strategic moves in medtech, including Heidelberg's acquisition, enhance capabilities in eye disease diagnostics and management.
---

EssilorLuxottica SA (ESLOY) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

ESLOY Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Jul 28, 20252025 (Q2)
- / -
1.618
Feb 12, 20252024 (Q4)
1.45 / 1.55
1.1337.61% (+0.43)
Jul 25, 20242024 (Q2)
1.99 / 1.62
1.65-1.94% (-0.03)
Feb 14, 20242023 (Q4)
1.52 / 1.13
1.16-2.59% (-0.03)
Jul 25, 20232023 (Q2)
1.93 / 1.65
1.34622.59% (+0.30)
Feb 23, 20232022 (Q4)
1.33 / 1.16
1.328-12.65% (-0.17)
Jul 29, 20222022 (Q2)
1.59 / 1.35
1.495-9.97% (-0.15)
Mar 11, 20222021 (Q4)
1.40 / 1.33
1.08422.51% (+0.24)
Jul 30, 20212021 (Q2)
1.45 / 1.50
-0.552370.83% (+2.05)
Mar 12, 20212020 (Q4)
- / 1.08
1.184-8.45% (-0.10)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---

ESLOY Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Feb 12, 2025$143.22$143.16-0.04%
Jul 25, 2024$106.15$104.67-1.39%
Feb 14, 2024$99.53$100.78+1.26%
Jul 25, 2023$96.11$96.50+0.41%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---

FAQ

When does EssilorLuxottica SA (ESLOY) report earnings?
EssilorLuxottica SA (ESLOY) is schdueled to report earning on Jul 28, 2025, TBA Not Confirmed.
    What is EssilorLuxottica SA (ESLOY) earnings time?
    EssilorLuxottica SA (ESLOY) earnings time is at Jul 28, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is ESLOY EPS forecast?
          ESLOY EPS forecast for the fiscal quarter 2025 (Q2) is 1.45.
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis